We are live on ! Find out more
VTVT icon

vTv Therapeutics
VTVT

31 hedge funds and large institutions have $5.58M invested in vTv Therapeutics in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.04% less ownership

Funds ownership: 0.18% → 0.14% (-0.04%)

26% less funds holding

Funds holding: 42 → 31 (-11)

36% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 11

46% less capital invested

Capital invested by funds: $10.3M → $5.58M (-$4.73M)

65% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 17

Holders
31
Holders Change
-11
Holders Change %
-26.19%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
11
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$285K
2
GCP
GSA Capital Partners
United Kingdom
+$218K
3
VF
Virtu Financial
New York
+$192K
4
Rafferty Asset Management
Rafferty Asset Management
New York
+$103K
5
Morgan Stanley
Morgan Stanley
New York
+$79.4K

Top Sellers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
-$554K
2
Marshall Wace
Marshall Wace
United Kingdom
-$469K
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$414K
4
Two Sigma Investments
Two Sigma Investments
New York
-$337K
5
Millennium Management
Millennium Management
New York
-$279K
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
26
Barclays
United Kingdom
$2K -$3.24K -43 -53%
PA
27
Parallel Advisors
California
$2K – – –
BNP Paribas Financial Markets
28
BNP Paribas Financial Markets
France
$1.39K -$151 -2 -8%
HF
29
HRT Financial
New York
– -$554K -6,081 Closed
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
– -$414K -4,540 Closed
Two Sigma Investments
31
Two Sigma Investments
New York
– -$337K -3,692 Closed
Jane Street
32
Jane Street
New York
– -$167K -1,832 Closed
CFG
33
Citizens Financial Group
Rhode Island
– -$160K -1,750 Closed
E
34
Ergoteles
New York
– -$124K -1,355 Closed
AQR Capital Management
35
AQR Capital Management
Connecticut
– -$120K -1,316 Closed
Susquehanna International Group
36
Susquehanna International Group
Pennsylvania
– -$97K -1,069 Closed
Two Sigma Advisers
37
Two Sigma Advisers
New York
– -$96K -1,058 Closed
Squarepoint
38
Squarepoint
New York
– -$66K -720 Closed
SFI
39
Susquehanna Fundamental Investments
Pennsylvania
– -$61K -669 Closed
XT
40
XTX Topco
Cayman Islands
– -$46K -501 Closed
PPA
41
Parametric Portfolio Associates
Washington
– -$28K -311 Closed
UBS Group
42
UBS Group
Switzerland
– -$24K -265 Closed
JP Morgan Chase
43
JP Morgan Chase
New York
– -$7K -76 Closed
Bank of America
44
Bank of America
North Carolina
– -$3.17K -42 -98%
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
– -$904 -12 -75%
MA
46
Montag & Associates
Georgia
– +$75 +1 New
1
2

VTVT Hedge Fund Activity: Q3 2021 in Review

31 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in vTv Therapeutics (VTVT) for Q3 2021, worth a combined $5.58M — down 46% from $10.3M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of VTVT and 6 opened new positions — a net loss of 11 holders — while 11 trimmed existing stakes and 7 added.

The largest buyer was Geode Capital Management, adding an estimated $285K. The largest seller was HRT Financial, exiting entirely with an estimated $554K sold.

  • 31 institutional investors held vTv Therapeutics (VTVT) as of Q3 2021, down from 42 in Q2 2021.
  • Funds reported $5.58M of vTv Therapeutics stock for Q3 2021, down 46% quarter-over-quarter.
  • 6 funds opened new vTv Therapeutics positions in Q3 2021 and 17 closed out, a net change of -11 holders.
  • The largest vTv Therapeutics buyer in Q3 2021 was Geode Capital Management, an estimated $285K added.
  • The largest vTv Therapeutics seller in Q3 2021 was HRT Financial, an estimated $554K sold.

Based on aggregated 13F filings for Q3 2021.